Related Experiment Videos
Apoptosis to HL-60 by humulone
H Tobe1, M Kubota, M Yamaguchi
1Showa College of Pharmaceutical Sciences, Tokyo, Japan.
Bioscience, Biotechnology, and Biochemistry
|June 1, 1997
Summary
Humulone, a hop extract compound, triggers programmed cell death (apoptosis) in leukemia cells. This bone resorption inhibitor
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Bone resorption is a critical process in bone remodeling and diseases.
- Hop extract contains compounds with potential therapeutic properties.
- Humulone is a known bone resorption inhibitor.
Purpose of the Study:
- To investigate the effect of humulone on apoptosis in cancer cell lines.
- To explore the relationship between humulone's apoptosis-inducing activity and its antioxidant properties.
Main Methods:
- Treatment of HL-60 cells with varying concentrations of humulone (1-100 µg/ml).
- Assessment of apoptosis induction.
- Evaluation of antioxidative activity.
Main Results:
- Humulone induced apoptosis in the HL-60 cell line.
- The apoptosis-inducing effect was observed within the concentration range of 1-100 µg/ml.
- A correlation was found between humulone's apoptosis-inducing and antioxidative activities.
Conclusions:
- Humulone exhibits potent apoptosis-inducing effects on leukemia cells.
- Antioxidative activity may play a role in humulone's ability to induce apoptosis.
- Humulone represents a potential therapeutic agent for leukemia.